Life Sciences Pulse

Life Sciences Pulse

Our Life Sciences Pulse strategy targets investments in innovative therapeutics, diagnostics, and life sciences tools companies.

Innovation is Accelerating

Life Sciences Pulse aims to invest in companies operating in specific business spaces and become their partners for long-term growth. Innovation is accelerating in the fields of therapeutics, diagnostics, and life sciences tools, and we often invest at their intersection. These confluences and new fields have the ability to transform how diseases are defined, diagnosed, and treated.

Our Investment Focus

Earth icon

Geography

U.S. based businesses
and international
life sciences hubs

Chart Icon

Stage

Businesses with clinical data
and/or meaningful
proof of concept

Chart icon

Investment Size

$25M – $40M

A Disciplined Approach to Investing in Life Sciences

Technologies measuring new aspects of biology enable novel methods to characterize disease, which in turn enables drug development that is more likely to benefit patients. Our disciplined approach to investing in life sciences hones in on businesses that are making advances in areas of large unmet medical need.

Tools companies are increasingly productive discovery engines. We look for businesses that are revenue-generating and that have the attractive potential for significant growth and profitability.

Driving the personalization of medicine. We are interested in investing in companies with meaningful proof-of-concept data, and/or regulatory clearance in the U.S., Europe, and/or other attractive geographies.

Dramatically improving patient outcomes. We look for businesses with compelling scientific foundations that address significant unmet medical need.

Partners for Long-term Growth

Sands Capital’s singular aim is to make long-term, concentrated investments in exceptional businesses. By leveraging our global research platform to source, assess, and structure investment opportunities, Sands Capital can partner with pioneers in the expanding class of innovative life sciences businesses and support them along their path to growth. 

Genomics Logo
Status: NASDAQ: TXG
Category: Life Sciences
Partner Since: April 2022
10X Genomics
1648827780
Genomics Logo

Show details

908 devices logo black orange title
Status: NASDAQ: MASS
Category: Life Sciences
Partner Since: April 2019
908 Devices
1554133440
908 devices logo black orange title

Show details

acrivon logo
Status: NASDAQ: ACRV
Category: Life Sciences
Partner Since: November 2021
Acrivon Therapeutics
1637077680
acrivon logo

Show details

Acumen pharmaceuticals logo title
Status: NASDAQ: ABOS
Category: Life Sciences
Partner Since: November 2020
Acumen Pharmaceuticals
1604245740
Acumen pharmaceuticals logo title

Show details

Ancora logo gray title gold
Status: Active
Category: Life Sciences
Partner Since: June 2021
Ancora Heart
1622562720
Ancora logo gray title gold

Show details

Ankyra logo
Status: Active
Category: Life Sciences
Partner Since: August 2021
Ankyra
1627819920
Ankyra logo

Show details

Archer logo title black
Status: Acquired
Category: Life Sciences
Partner Since: December 2019
ArcherDx
1575164400
Archer logo title black

Show details

BioSplice gray logo title
Status: Active
Category: Life Sciences
Partner Since: March 2021
BioSplice Therapeutics
1614560460
BioSplice gray logo title

Show details

Cincor logo
Status: NASDAQ: CINC
Category: Life Sciences
Partner Since: January 2022
CinCor Pharma
1641039240
Cincor logo

Show details

Cleerly Logo
Status: Active
Category: Life Sciences
Partner Since: July 2022
Cleerly
1656673260
Cleerly Logo

Show details

Cytrellis logo title blue orange
Status: Active
Category: Life Sciences
Partner Since: December 2020
Cytrellis
1606784460
Cytrellis logo title blue orange

Show details

Status: NASDAQ: DICE
Category: Life Sciences
Partner Since: July 2018
DiCE Molecules
1530406860

Show details

Earli logo
Status: Active
Category: Life Sciences
Partner Since: January 2021
Earli
1609462860
Earli logo

Show details

Elephas logo
Status: Active
Category: Life Sciences
Partner Since: September 2021
Elephas
1630458060
Elephas logo

Show details

Exo imaging logo title green black
Status: Active
Category: Life Sciences
Partner Since: May 2021
Exo Imaging
1619830860
Exo imaging logo title green black

Show details

freenome title logo black
Status: Active
Category: Life Sciences
Partner Since: July 2019
Freenome
1561942860
freenome title logo black

Show details

Inspirna logo
Status: Active
Category: Life Sciences
Partner Since: June 2022
Inspirna
1654048920
Inspirna logo

Show details

Karuna therapeutics
Status: NASDAQ: KRTX
Category: Life Sciences
Partner Since: March 2019
Karuna
1551402060
Karuna therapeutics

Show details

Luminoah logo
Status: Active
Category: Life Sciences
Partner Since: August 2021
Luminoah
1627799640
Luminoah logo

Show details

mekonos logo
Status: Active
Category: Life Sciences
Partner Since: October 2021
Mekonos
1633070460
mekonos logo

Show details

nucleix
Status: Active
Category: Life Sciences
Partner Since: December 2021
Nucleix
1638341400
nucleix

Show details

Load More

A Bold Mission Requires a Strong Team

Sands Capital has a single, integrated team focused on private markets, that collaborates to support the execution of the Life Sciences Pulse strategy. We have sought out individuals who share our passions and are integrated with the broader Sands Capital investment team. The Life Sciences Pulse team is comprised of senior professionals across public and private markets, with founders, operators, PhDs and experienced investors leading our team.

Group of people
Parker Cassidy

Parker Cassidy

Partner

man in striped shirt and jacket smiles at the camera

Michael J. Ginder, CFA

Partner

a man with gray hair wearing a black jacket and striped shirt smiles at the camera

Ian Ratcliffe

Executive Managing Partner
Executive Managing Director

red-haired man in a checkered shirt in a jacket smiles at the camera

Stephen Zachary, PhD

Managing Partner

Padmaparna Chaudhuri

Padmaparna Chaudhuri, PhD

Director of Technical Research

a woman in black slightly curly hair wearing a gray cape and a black shirt smiles at the camera

Jennifer Goldsmith

Sr. Research Analyst
Director, Research Associate Program

Aagam Shah

Aagam Shah, PhD

Sr. Associate

Shreya Singh

Shreya Singh

Associate

Andrew Giordano

Andrew P. Giordano

Managing Director, Business Development and Client Relations

Scott Headd

Scott Headd

Sr. Director, Client Relations

a woman in a black blouse looking at the camera

Miriam Z. Sanders

Director, Investor Relations

Alexandra Fulk

Alexandra Fulk

Chief Compliance Officer, Sr. Counsel

a woman with brown hair and brown eyes wearing a necklace in a black blouse smiles at the camera

Yolande J. Hanlan

Director, Sr. Counsel

Morgan Lee

Morgan Lee

Legal Counsel

Related Insights

Investment Strategy
Digital Devices are Enabling a Healthier World
Healthcare companies are leveraging advances in technology to make smarter and smaller medical devices that enable earlier diagnosis and better treatment of disease.

Disclosures:

As of October 1, 2021, Sands Capital was redefined to be the combination of Sands Capital Management, LLC and Sands Capital Ventures. Both firms are registered investment advisers with the United States Securities and Exchange Commission in accordance with the Investment Advisers Act of 1940. The two registered investment advisers are combined to be one firm and are doing business as Sands Capital. Sands Capital operates as a distinct business organization, retains discretion over the assets between the two registered investment advisers, and has autonomy over the total investment decision-making process.

Investment in a fund involves significant risk. The Life Sciences Pulse strategy is concentrated in a limited number of holdings in the life sciences industry. Some of the risks impacting this industry include cybersecurity risk, supply chain disruption, regulatory risk, geopolitical risk, cryptocurrency risk, intellectual property risk and product liability risk. The fund is also subject to risks related to investments in China. No assurance can be given that a fund’s investment objectives will be achieved. An investment is only suitable for sophisticated investors for whom an investment does not constitute a complete investment program, who have experience with similar types of investments, and who understand, are willing to assume, and have the financial resources necessary to withstand the significant risks involved in the investment, including the potential for a complete loss of capital. Please review the risks outlined in the Private Placement Memorandum prior to investing.

The activities of the Life Sciences Pulse Team, including investment due diligence and sourcing, may be supported on an ad hoc basis by various members of the broader global research team of Sands Capital Management. Please refer to the biographies of the Life Sciences Pulse Strategy Team members. Members of the Life Sciences Pulse team also provide services with respect to other strategies of Sands Capital.

The logos and website images used are used for illustrative purposes only and were obtained directly from the relevant companies’ websites. The logo and website images are trademarks or registered trademarks of the companies and their use on this webpage does not imply any connection between us and the companies.

Target investment size is current as of 3/31/2023